Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomaterials USA LLC is a life science tools and materials company headquartered in Richmond, Virginia, with a global presence including offices in Canada and China. The company specializes in the development and manufacture of advanced 2D and 3D cell culture supplies, non-viral transfection agents, and a diverse range of biomaterials such as scaffolds, nanoparticles, and hydrogels. Its flagship product lines include the CellSphere™ 3D cell culture plates, MaxFection™ transfection reagents, and the CellPhilic™ series of hydrogels and hyaluronic acid. Biomaterials USA serves the global research community, supporting critical applications in stem cell research, tissue engineering, and gene delivery. In addition to its core research products, the company offers dietary supplements through its Topia USA® and Novis Vita® brands. The company's technologies are widely utilized in academic and industrial laboratories for robust cell growth and differentiation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomaterials USA.